Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFα therapy

Por S. Hertrampf, J. Klotsche, Q. Schefer, A. M. Glimm, G. R. Burmester, P. Hoff, G. Schmittat, T. Häupl, S. Hermann, M. Backhaus, Sarah Ohrndorf
Publicado em 2022-05-01